Current Report Filing (8-k)

false000149229800014922982022-01-242022-01-24

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 24, 2022

SABRA HEALTH CARE REIT, INC.

(Exact name of registrant as specified in its charter)

 

Maryland

001-34950

27-2560479

(State of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

 

18500 Von Karman Avenue

Suite 550

Irvine

CA

92612

(Address of principal executive offices)

(Zip Code)

Registrant's telephone number including area code: [phone]  

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading symbol(s)			Name of each exchange on which registered
Common stock, $0.01 par value			SBRA			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company			☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

Item 5.02			Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 24, 2022, Ronald G. Geary notified the Board of Directors of Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) of his resignation from Sabra’s Board of Directors, effective immediately. Mr. Geary’s resignation is for health reasons and does not relate to any disagreement on matters relating to the Company’s operations, policies or practices or any other matter.

On behalf of the Board of Directors, Richard K. Matros, the Company’s Chair and Chief Executive Officer, thanked Mr. Geary for his dedicated and thoughtful service to the Board.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

			SABRA HEALTH CARE REIT, INC.
Date: January 25, 2022			/S/    MICHAEL COSTA
			Name:						Michael Costa
			Title:						Chief Financial Officer, Secretary and Executive Vice President